The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus

Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene modulation: A comprehensive review

(2020) Keum Hwa Lee et al.   AUTOIMMUNITY REVIEWS

Precision medicine in the care of rheumatoid arthritis: Focus on prediction and prevention of future clinically-apparent disease

(2020) Michael Mahler et al.   AUTOIMMUNITY REVIEWS

Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases

(2020) Karsten Conrad et al.   AUTOIMMUNITY REVIEWS

Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors

(2020) Caterina Bodio et al.   AUTOIMMUNITY REVIEWS

Usefulness of vasculitis biomarkers in the era of the personalized medicine

(2020) Elena Csernok et al.   AUTOIMMUNITY REVIEWS

Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels

(2020) Ruben L. Smeets et al.   AUTOIMMUNITY REVIEWS

Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases

(2019) Jaume Alijotas-Reig et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes

(2019) Piero Ruscitti et al.   MEDICINE

Refractory lupus nephritis: When, why and how to treat

(2019) Andreas Kronbichler et al.   AUTOIMMUNITY REVIEWS

EULAR recommendations for the management of antiphospholipid syndrome in adults

(2019) Maria G Tektonidou et al.   ANNALS OF THE RHEUMATIC DISEASES

Body mass index as a driver of selection of biologic therapy in rheumatoid arthritis. Results from the US-CLARA study

(2019) Marco Di Carlo et al.   European Journal of Internal Medicine

Predictive value of serum amyloid A levels for requirement of concomitant methotrexate in tocilizumab initiation: A post-hoc analysis of the SURPRISE study

(2019) Masaru Kato et al.   Modern Rheumatology

An update on pathogenesis of psoriatic arthritis and potential therapeutic targets

(2019) Maria Sole Chimenti et al.   Expert Review of Clinical Immunology

Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases✰

(2019) Yoshiya Tanaka et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification

(2019) Efstathia K. Kapsogeorgou et al.   JOURNAL OF AUTOIMMUNITY

Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets

(2019) Daniel Aletaha et al.   Nature Reviews Rheumatology

Therapeutic apheresis during pregnancy: A single center experience

(2019) Anna Colpo et al.   TRANSFUSION AND APHERESIS SCIENCE

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

(2019) Piero Ruscitti et al.   PLOS MEDICINE

EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies

(2019) Manuel Ramos-Casals et al.   ANNALS OF THE RHEUMATIC DISEASES

The Pathogenesis of Ankylosing Spondylitis: an Update

(2019) Susanne Juhl Pedersen et al.   Current Rheumatology Reports

Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents

(2019) Andrea Rubbert-Roth et al.   AUTOIMMUNITY REVIEWS

Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database

(2019) Camelia Frantz et al.   AUTOIMMUNITY REVIEWS

From autoinflammation to autoimmunity: old and recent findings

(2018) Francesco Caso et al.   CLINICAL RHEUMATOLOGY

Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis

(2018) C-B Choi et al.   LUPUS

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

(2018) Keith M. Sullivan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy

(2018) Ada Aita et al.   PLoS One

Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis

(2018) Ippei Miyagawa et al.   RHEUMATOLOGY

Antiphospholipid syndrome: An update on risk factors for pregnancy outcome

(2018) Sara De Carolis et al.   AUTOIMMUNITY REVIEWS

Lymphomagenesis in Sjögren's syndrome: Predictive biomarkers towards precision medicine

(2018) Andreas V. Goules et al.   AUTOIMMUNITY REVIEWS

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis

(2018) Roberto Giacomelli et al.   AUTOIMMUNITY REVIEWS

Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges

(2017) Soheil Tavakolpour   IMMUNOLOGY LETTERS

Could Anticoagulation or Antiaggregation Treatment Be Ceased in Patients With Primary Antiphospholipid Syndrome When Antiphospholipid Antibodies Become Persistently Negative?

(2017) Fehmi Hindilerden et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study

(2017) Xavier Mariette et al.   JOINT BONE SPINE

Axial spondyloarthritis

(2017) Joachim Sieper et al.   LANCET

Anticoagulation withdrawal in antiphospholipid syndrome: a retrospective matched-control study

(2017) C M Yelnik et al.   LUPUS

Cessation of oral anticoagulants in antiphospholipid syndrome

(2017) C Comarmond et al.   LUPUS

Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study

(2017) Piero Ruscitti et al.   PLoS One

Serological evolution in women with positive antiphospholipid antibodies

(2017) Leyre Riancho-Zarrabeitia et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

(2017) Simon J. Bowman et al.   Arthritis & Rheumatology

Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment

(2016) Konstantina Delli et al.   ANNALS OF THE RHEUMATIC DISEASES

Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome—A Retrospective Analysis and a Review of Additional Treatment in Pregnancy

(2016) Karoline Mayer-Pickel et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study

(2016) Seong-Kyu Kim et al.   CLINICAL RHEUMATOLOGY

Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review

(2016) Anne Contis et al.   CLINICAL RHEUMATOLOGY

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)

(2016) Florenzo Iannone et al.   CLINICAL RHEUMATOLOGY

Body mass index and response to abatacept in rheumatoid arthritis

(2016) Anais Gardette et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?

(2016) Roberto Giacomelli et al.   Expert Review of Clinical Immunology

Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome

(2016) Divi Cornec et al.   JOURNAL OF AUTOIMMUNITY

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

(2016) Eleftheria Lefkou et al.   JOURNAL OF CLINICAL INVESTIGATION

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

(2016) Amelia Ruffatti et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry

(2016) Bente Glintborg et al.   JOURNAL OF RHEUMATOLOGY

Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics

(2016) Joachim Sieper et al.   RHEUMATOLOGY

Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice

(2016) Javier Narváez et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Relationship Between Baseline and Early Changes in C-Reactive Protein and Interleukin-6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis

(2016) Jianmei Wang et al.   ARTHRITIS CARE & RESEARCH

Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2016) Yang Liu et al.   ARTHRITIS CARE & RESEARCH

The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study

(2015) Arsène Mekinian et al.   AUTOIMMUNITY REVIEWS

Strengths and limitations of industry vs. academic randomized controlled trials

(2015) P.-F. Laterre et al.   CLINICAL MICROBIOLOGY AND INFECTION

Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients

(2015) Florenzo Iannone et al.   JOINT BONE SPINE

Body Mass Index and response to rituximab in rheumatoid arthritis

(2015) Sébastien Ottaviani et al.   JOINT BONE SPINE

Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical Trials

(2015) X. Baraliakos et al.   JOURNAL OF RHEUMATOLOGY

Association of Body Mass Index Categories with Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis: A Systematic Review and Metaanalysis

(2015) C. Vidal et al.   JOURNAL OF RHEUMATOLOGY

Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient

(2015) Y.-M. Pers et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

(2015) Yoshiya Tanaka et al.   Modern Rheumatology

A New Initiative on Precision Medicine

(2015) Francis S. Collins et al.   NEW ENGLAND JOURNAL OF MEDICINE

A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis

(2015) Emily S. Collins et al.   Proteomics Clinical Applications

Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block

(2015) Amelia Ruffatti et al.   TRANSFUSION AND APHERESIS SCIENCE

Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies

(2015) Francesco Caso et al.   Therapeutic Advances in Chronic Disease

Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)

(2015) Keisuke Izumi et al.   PLoS One

Treatment of Primary Sjögren Syndrome With Rituximab

(2014) Valérie Devauchelle-Pensec et al.   ANNALS OF INTERNAL MEDICINE

Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis

(2014) Opeyemi S Ademowo et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Rituximab on Serum Levels of Anti-C1q and Antineutrophil Cytoplasmic Autoantibodies in Refractory Severe Lupus Nephritis

(2014) Jin Zhang et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

B-cell hyperactivity in primary Sjögren's syndrome

(2014) Frans GM Kroese et al.   Expert Review of Clinical Immunology

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

(2014) Jacob M. van Laar et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The classification and diagnostic criteria of ankylosing spondylitis

(2014) Siba P. Raychaudhuri et al.   JOURNAL OF AUTOIMMUNITY

Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab

(2014) Daisuke Hoshi et al.   Modern Rheumatology

Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complications

(2014) Yuko Matsuki et al.   Modern Rheumatology

Targeting inflammation in the treatment of type 2 diabetes: time to start

(2014) Marc Y. Donath   NATURE REVIEWS DRUG DISCOVERY

Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register

(2014) Helena Forsblad-d’Elia et al.   RHEUMATOLOGY

Long-term data on tacrolimus treatment in lupus nephritis

(2014) Desmond Y. H. Yap et al.   RHEUMATOLOGY

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity

(2014) Elisa Salvan et al.   THROMBOSIS AND HAEMOSTASIS

Pregnancy Morbidity in Antiphospholipid Syndrome: What Is the Impact of Treatment?

(2014) Guilherme R. de Jesús et al.   Current Rheumatology Reports

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

(2014) Maxime Dougados et al.   Arthritis & Rheumatology

Use of Whole-Blood Transcriptomic Profiling to Highlight Several Pathophysiologic Pathways Associated With Response to Rituximab in Patients With Rheumatoid Arthritis: Data From a Randomized, Controlled, Open-Label Trial

(2014) Jérémie Sellam et al.   Arthritis & Rheumatology

The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

(2013) Luca Quartuccio et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis

(2013) E. William St.Clair et al.   ARTHRITIS AND RHEUMATISM

CCL19, a B Cell Chemokine, Is Related to the Decrease of Blood Memory B Cells and Predicts the Clinical Response to Rituximab in Patients With Rheumatoid Arthritis

(2013) Jérémie Sellam et al.   ARTHRITIS AND RHEUMATISM

Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative

(2013) Emmanuel Coloma Bazán et al.   IMMUNOLOGIC RESEARCH

Longterm Effects of Rituximab on B Cell Counts and Autoantibody Production in Rheumatoid Arthritis: Use of High-sensitivity Flow Cytometry for More Sensitive Assessment of B Cell Depletion

(2013) A. Vancsa et al.   JOURNAL OF RHEUMATOLOGY

Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis

(2013) V. Chandran et al.   JOURNAL OF RHEUMATOLOGY

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

(2013) V. Pengo et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis

(2013) RJ Davies et al.   LUPUS

Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response

(2013) T. Jonsdottir et al.   RHEUMATOLOGY

Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice

(2013) Yves-Marie Pers et al.   RHEUMATOLOGY

Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab

(2012) Vanessa E Hogan et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

(2012) Jacques-Eric Gottenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies

(2012) Michael D. Lockshin et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Levels of Circulating Th17 Cells and Regulatory T Cells in Ankylosing Spondylitis Patients with an Inadequate Response to Anti−TNF-α Therapy

(2012) Li Xueyi et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis

(2012) Marc Weidenbusch et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients

(2012) A. Ruyssen-Witrand et al.   RHEUMATOLOGY

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine

(2012) Elisa Gremese et al.   ARTHRITIS CARE & RESEARCH

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity

(2012) YK Onno Teng et al.   ARTHRITIS RESEARCH & THERAPY

B lymphocyte-typing for prediction of clinical response to rituximab

(2012) Hans-Peter Brezinschek et al.   ARTHRITIS RESEARCH & THERAPY

High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome

(2011) MICHAL J. SIMCHEN et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

(2011) Jérémie Sellam et al.   ARTHRITIS AND RHEUMATISM

HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype

(2011) Robert Winchester et al.   ARTHRITIS AND RHEUMATISM

Emerging biological drugs: A new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

(2011) Giuseppe Murdaca et al.   AUTOIMMUNITY REVIEWS

First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss

(2011) K. Bramham et al.   BLOOD

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study

(2011) A. Ruffatti et al.   RHEUMATOLOGY

A Plasmablast Biomarker for Nonresponse to Antibody Therapy to CD20 in Rheumatoid Arthritis

(2011) K. Owczarczyk et al.   Science Translational Medicine

Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy - a single centre, open-label study

(2011) Eliza K Pontifex et al.   ARTHRITIS RESEARCH & THERAPY

Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

(2010) S. B. Cohen et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

(2010) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity

(2010) T. G. Kormelink et al.   ANNALS OF THE RHEUMATIC DISEASES

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

(2010) P. P. Tak et al.   ANNALS OF THE RHEUMATIC DISEASES

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial

(2010) J. M. Meijer et al.   ARTHRITIS AND RHEUMATISM

Management of nonresponse to rituximab in rheumatoid arthritis: Predictors and outcome of re-treatment

(2010) E. M. Vital et al.   ARTHRITIS AND RHEUMATISM

Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute-phase reactants

(2010) Josef S. Smolen et al.   ARTHRITIS AND RHEUMATISM

Body mass index and clinical response to infliximab in rheumatoid arthritis

(2010) Ruth Klaasen et al.   ARTHRITIS AND RHEUMATISM

The CC homozygosis of the −174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis

(2010) Martina Fabris et al.   AUTOIMMUNITY REVIEWS

Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial

(2010) P. J. MEASE et al.   JOURNAL OF RHEUMATOLOGY

Obesity in rheumatoid arthritis

(2010) A. Stavropoulos-Kalinoglou et al.   RHEUMATOLOGY

CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis

(2010) S. Rosengren et al.   RHEUMATOLOGY

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

(2010) A. Rubbert-Roth et al.   RHEUMATOLOGY

Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment

(2009) J M Meijer et al.   ANNALS OF THE RHEUMATIC DISEASES

Prospective new biological therapies for rheumatoid arthritis

(2009) Ladislav Šenolt et al.   AUTOIMMUNITY REVIEWS

Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis

(2009) M. RUDWALEIT et al.   JOURNAL OF RHEUMATOLOGY

Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients

(2009) M. Garcia-Carrasco et al.   LUPUS

Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome

(2009) K. Bramham et al.   LUPUS

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study

(2009) John N. Boletis et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue

(2008) A W R van Kuijk et al.   ANNALS OF THE RHEUMATIC DISEASES

Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation

(2008) Y K O Teng et al.   ANNALS OF THE RHEUMATIC DISEASES

Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study

(2008) S Dass et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment

(2008) Petra Roll et al.   ARTHRITIS AND RHEUMATISM

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

(2008) Shouvik Dass et al.   ARTHRITIS AND RHEUMATISM

Retirada de la anticoagulación en el síndrome antifosfolípido primario cuando se negativizan los anticuerpos anticardiolipina

(2008) J. Criado-García et al.   REVISTA CLINICA ESPANOLA

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

(2008) Antonio Naranjo et al.   ARTHRITIS RESEARCH & THERAPY